共 8 条
[1]
Tissue renin-angiotensin systems inthe heart and vasculature:possible involvement in the car-diovascular actions of converting enzyme inhibitors. Unger T,Gohlke P. American Journal of Chinese Medicine . 1990
[2]
Processing of an-giotensin Ⅱ(A-Ⅱ) and(Sar1, Ala8 3) A-Ⅱ by culturedbovine adrenocortical cells. Crozat A,Penhoat A,Saez JM. The Journal of Endocrinology . 1986
[3]
Comparativestudies of tissue inbibition by angiotensin converting en-zyme inhibitors. Johnston CI,Fabris B.Yamada H,et al. Journal of Hypertension . 1989
[4]
Effects of losartanon angiotensin and bradykinin peptides and angiotensin-converting enzyme. Campbell DJ,Kladis A,Valentijn AJ. Journal of Cardiovascular Pharmacology . 1995
[5]
Effects of losartan,a nonpeptides angiotensin Ⅱreceptor antagonist,oncardiac hypertrophy and the tissue angiotensin content inspontaneously hypertensive rats. Mizuno K,Taui M.Hashimoto S,et al. Life Sciences . 1992
[6]
Endotheli-um removal does nor abolish angiotensin converting enzymeactivity from the mesenteric bed of the rat. Pipili-Synetos E,Sideri E,Catravas JD. et al. Biochemistry and Pharmacology . 1990
[7]
Mdchanisms respon-sible for sustained byptension after captopril treatment. Chen DG,Jin XQ,Wang HJ,et al. Journal of Hypertension . 1995
[8]
Control of hypertrophic versus byperplasticgrowth of vascular smooth cells. Owen GK. American Journal of Physiology . 1989